Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study reveals why diabetic cats are often misdiagnosed
Cat
“It has been common practice to automatically suspect a cat with Diabetes Mellitus to be suffering from a form of diabetes akin to human type 2."

One in four cases caused by hypersomatotropism

One in four cases of Diabetes Mellitus in cats are caused by excess secretion of pituitary growth hormone, according to research by the RVC.

The findings, published in PLOS ONE, reveal that this is much more common than previously thought, and cats with this condition can be easily misdiagnosed as having primary (type 2) diabetes.

Researchers collected data between 2003 and 2011 on over 1200 diabetic cats treated at veterinary practices across the UK.

They found that the presence of diabetes in one in four cats can be explained by hypersomatotropism - a state caused by a pituitary benign tumour which can be effectively treated by one operation in specialist centres.

However, just 24 per cent of clinicians who submitted samples suspected this was the case, as most hypersomatotropism cats did not display typical signs. Instead, they displayed symptoms indistinguishable from cats with primary (type 2) diabetes.  

The RVC say this suggests that hypersomatotropism screening should be considered when treating diabetic cats.   Lead researcher Dr Stijn Niessen, explains: 

“It has been common practice to automatically suspect a cat with Diabetes Mellitus to be suffering from a form of diabetes akin to human type 2.

"The current study suggests that this is an oversimplification. Approximately one in four of assessed diabetic cats were actually found to be suffering from hypersomatotropism-induced Diabetes Mellitus, which requires specific treatment and manifests itself very differently as it develops."

“Interestingly, only a small proportion of clinicians reported they strongly suspected acromegaly to be present on the basis of the clinical picture. These data therefore highlight the need for veterinarians working with the spontaneously diabetic cat to consider routinely screening for the presence of hypersomatotropism-induced Diabetes Mellitus, given the significant clinical consequences of its presence.

“Should the hypersomatotropism be diagnosed and treated with one operation, most cats will enter a state of diabetic remission. If it remains undiagnosed, diabetic cats tend to be difficult to regulate glycaemically which often results in euthanasia, or in the long-term, they will suffer from other growth hormone-induced negative conditions such as heart disease, as well as central nervous system problems.”

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.